(Q36688241)

15 August 2017

1 reference

title

The ABCs (Antibody, B cells, and Carbohydrate epitopes) of cholera immunity: considerations for an improved vaccine (English)

1 reference

15 August 2017

0 references

1

Daniele Provenzano

1 reference

15 August 2017

Pavol Kovác

2

1 reference

15 August 2017

William F Wade

series ordinal

3

1 reference

15 August 2017

publication date

1 January 2006

1 reference

Microbiology and Immunology

15 August 2017

published in

1 reference

15 August 2017

volume

50

1 reference

15 August 2017

issue

12

1 reference

15 August 2017

page(s)

899-927

1 reference

Supplementation with zinc, but not vitamin A, improves seroconversion to vibriocidal antibody in children given an oral cholera vaccine

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Herd immunity conferred by killed oral cholera vaccines in Bangladesh: a reanalysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

B1b lymphocytes confer T cell-independent long-lasting immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

LPS augments human B-cell differentiation by direct stimulation of PWM-responsive B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

CXCL13 is required for B1 cell homing, natural antibody production, and body cavity immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Marginal zone, but not follicular B cells, are potent activators of naive CD4 T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Origins and functions of B-1 cells with notes on the role of CD5

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Interaction of campylobacter species with antibody, complement and phagocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

The CD40-CD154 interaction in B cell-T cell liaisons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Human secretory immunoglobulin A may contribute to biofilm formation in the gut.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

The toll-like receptor repertoire of human B lymphocytes: inducible and selective expression of TLR9 and TLR10 in normal and transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Characteristics of IgVH genes used by human intestinal plasma cells from childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Human intestinal IgA response is generated in the organized gut-associated lymphoid tissue but not in the lamina propria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Preparation, immunogenicity, and protective efficacy, in a murine model, of a conjugate vaccine composed of the polysaccharide moiety of the lipopolysaccharide of Vibrio cholerae O139 bound to tetanus toxoid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

A simple and convenient microtiter plate assay for the detection of bactericidal antibodies to Vibrio cholerae O1 and Vibrio cholerae O139

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Role of secretory antibodies in the defence against infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

New developments in the understanding of cholera

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Can oral cholera vaccination play a role in controlling a cholera outbreak?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Structural and functional analyses of bacterial lipopolysaccharides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

The complement system in regulation of adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Linkages of innate and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Mechanisms of Antibacterial Immunity against Vibrio cholerae in the Intestinal Tracts of Baby Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Lipopolysaccharides of Vibrio cholerae. I. Physical and chemical characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Defective macrophage function in neonates and its impact on unresponsiveness of neonates to polysaccharide antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Field trial of oral cholera vaccines in Bangladesh: evaluation of anti-bacterial and anti-toxic breast-milk immunity in response to ingestion of the vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Field trial of oral cholera vaccines in Bangladesh: serum vibriocidal and antitoxic antibodies as markers of the risk of cholera.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Generation of immune memory by haptenated derivatives of thymus-independent antigens in C57BL/6 mice. I. The differentiation of memory B lymphocytes into antibody-secreting cells depends on the nature of the thymus-independent carrier used for memor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Secondary antibody responses to thymus-independent antigens. Decline and life-span of memory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Human infection with Ascaris lumbricoides is associated with suppression of the interleukin-2 response to recombinant cholera toxin B subunit following vaccination with the live oral cholera vaccine CVD 103-HgR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

IgM: mucosal response in acute diarrhoeal disease of infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

A high proportion of Vibrio cholerae strains isolated from children with diarrhoea in Bangkok, Thailand are multiple antibiotic resistant and belong to heterogenous non-O1, non-O139 O-serotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Heterogeneity of tonsillar subepithelial B lymphocytes, the splenic marginal zone equivalents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Production and characterization of monoclonal antibodies to E1 Tor toxin co-regulated pilus of Vibrio cholerae

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Peptides mimicking Vibrio cholerae O139 capsular polysaccharide elicit protective antibody response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Immunoglobulin A cell distribution in the human small intestine: phenotypic and functional characteristics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Self-limiting nature of seasonal cholera epidemics: Role of host-mediated amplification of phage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Human IgA- and IgM-secreting intestinal plasma cells carry heavily mutated VH region genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Safety and immunogenicity of a proteosome-Shigella flexneri 2a lipopolysaccharide vaccine administered intranasally to healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

How antibodies act as natural adjuvants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Protection against cholera in breast-fed children by antibodies in breast milk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Rapid detection of Vibrio cholerae O:1 by motility inhibition and immunofluorescence with monoclonal antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

B-1a and B-1b cells exhibit distinct developmental requirements and have unique functional roles in innate and adaptive immunity to S. pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Calibrated serological techniques demonstrate significant different serum response rates to an oral killed cholera vaccine between Swedish and Nicaraguan children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Surface epithelium related activation of complement differs in Crohn's disease and ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Blood group, immunity, and risk of infection with Vibrio cholerae in an area of endemicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Toxin, toxin-coregulated pili, and the toxR regulon are essential for Vibrio cholerae pathogenesis in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Serological Cross‐Reaction between Intact and Chemically Modified Lipopolysaccharides of O1 Vibrio cholerae Inaba and Non‐O1 V. cholerae Bio‐Serogroup Hakata

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Intestinal and systemic immune responses in humans after oral immunization with a bivalent B subunit-O1/O139 whole cell cholera vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Absence of epithelial immunoglobulin A transport, with increased mucosal leakiness, in polymeric immunoglobulin receptor/secretory component-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Selective IgA deficiency in Japanese blood donors: frequency and statistical analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Origin of murine B cell lineages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Haemophilus influenzae type b conjugate vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Immunological memory: the role of B cells in long-term protection against invasive bacterial pathogens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

The complex mechanism of antibody-mediated clearance of Bordetella from the lungs requires TLR4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

TcpF is a soluble colonization factor and protective antigen secreted by El Tor and classical O1 and O139 Vibrio cholerae serogroups

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

The suckling mouse model of cholera

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Antibody formation in mouse bone marrow during secondary type responses to various thymus-independent antigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Refractory periods and climate forcing in cholera dynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Cells in the marginal zone of the spleen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Age-dependent development of the splenic marginal zone in human infants is associated with different causes of death

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Effect of small bowel bacterial overgrowth on the immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Human memory B cells transferred by allogenic bone marrow transplantation contribute significantly to the antibody repertoire of the recipient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Protective immunity of pneumococcal glycoconjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

The binding of synthetic analogs of the upstream, terminal residue of the O-polysaccharides (O-PS) of Vibrio cholerae O:1 serotypes Ogawa and Inaba to two murine monoclonal antibodies (MAbs) specific for the Ogawa lipopolysaccharide (LPS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Development and selection of marginal zone B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Isolated lymphoid follicles can function as sites for induction of mucosal immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Effectiveness of mass oral cholera vaccination in Beira, Mozambique

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Peyer's patches: organized lymphoid structures for the induction of mucosal immune responses in the intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Humoral immunity and long-lived plasma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Memory B-cell persistence is independent of persisting immunizing antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Synthetic fragments of Vibrio cholerae O1 Inaba O-specific polysaccharide bound to a protein carrier are immunogenic in mice but do not induce protective antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Induction and differentiation of B memory cells by a thymus-independent antigen, trinitrophenylated lipopolysaccharide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Identification of hepoxilin A3 in inflammatory events: a required role in neutrophil migration across intestinal epithelia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Antibodies (IgG) to lipopolysaccharide of Vibrio cholerae O1 mediate protection through inhibition of intestinal adherence and colonisation in a mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Oral administration of lipopolysaccharides activates B-1 cells in the peritoneal cavity and lamina propria of the gut and induces autoimmune symptoms in an autoantibody transgenic mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

The radioprotective 105/MD-1 complex links TLR2 and TLR4/MD-2 in antibody response to microbial membranes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Immunological Properties ofVibrio choleraeLipopolysaccharides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Characterization of Vibrio cholerae O1 El tor galU and galE mutants: influence on lipopolysaccharide structure, colonization, and biofilm formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Germline antibody recognition of distinct carbohydrate epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Lamina propria dendritic cells in the physiology and pathology of the gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Generation of migratory antigen-specific plasma blasts and mobilization of resident plasma cells in a secondary immune response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

The toll-like receptor protein RP105 regulates lipopolysaccharide signaling in B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Marginal zone B cells exhibit unique activation, proliferative and immunoglobulin secretory responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Regulation of antigen receptor gene assembly in lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Model-building study of the combining sites of two antibodies to alpha (1----6)dextran

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Signaling in B cells via Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Antigen-specific immunoglobulin A antibodies secreted from circulating B cells are an effective marker for recent local immune responses in patients with cholera: comparison to antibody-secreting cell responses and other immunological markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Acute dehydrating disease caused by Vibrio cholerae serogroups O1 and O139 induce increases in innate cells and inflammatory mediators at the mucosal surface of the gut

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Randomized, controlled study of the safety and immunogenicity of Peru-15, a live attenuated oral vaccine candidate for cholera, in adult volunteers in Bangladesh

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Efficacy trial of single-dose live oral cholera vaccine CVD 103-HgR in North Jakarta, Indonesia, a cholera-endemic area

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Antibody responses after immunization with killed oral cholera vaccines during the 1985 vaccine field trial in Bangladesh

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Classification of B-cells according to their differentiation status, their micro-anatomical localisation and their developmental lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Incomplete correlation of serum vibriocidal antibody titer with protection from Vibrio cholerae infection in urban Bangladesh

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Effect of saccharide length on the immunogenicity of neoglycoconjugates from synthetic fragments of the O-SP of Vibrio cholerae O1, serotype Ogawa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Activation and suppression of the proinflammatory immune response by Vibrio cholerae toxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Safety, immunogenicity, and transmissibility of single-dose live oral cholera vaccine strain CVD 103-HgR in 24- to 59-month-old Indonesian children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Subclass distribution of natural salivary IgA antibodies against pneumococcal capsular polysaccharide of type 14 and pneumococcal surface adhesin A (PsaA) in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Immune response to pneumococcal polysaccharides 4 and 14 in elderly and young adults: analysis of the variable light chain repertoire

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Serotype conversion in Vibrio cholerae O1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Safety and immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR in 5-9-year-old Indonesian children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Antibodies directed against the toxin-coregulated pilus isolated from Vibrio cholerae provide protection in the infant mouse experimental cholera model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Progress towards development of a cholera subunit vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

A Vibrio cholerae classical TcpA amino acid sequence induces protective antibody that binds an area hypothesized to be important for toxin-coregulated pilus structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Field trial of a locally produced, killed, oral cholera vaccine in Vietnam

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Enhanced mucosal and systemic immune responses to Helicobacter pylori antigens through mucosal priming followed by systemic boosting immunizations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Crystal structure of an anti-carbohydrate antibody directed against Vibrio cholerae O1 in complex with antigen: Molecular basis for serotype specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

On the antigenic determinants of the lipopolysaccharides of Vibrio cholerae O:1, serotypes Ogawa and Inaba

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Kinetics of the vibriocidal antibody response to live oral cholera vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Gender, age and seasonal effects on IgA deficiency: a study of 7293 Caucasians

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Human blood IgM "memory" B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Antibacterial action of specific IgA and transport of IgM, IgA, and IgG from serum into the small intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Clearance of Bordetella parapertussis from the lower respiratory tract requires humoral and cellular immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

CD19 regulates innate immunity by the toll-like receptor RP105 signaling in B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Human neonatal Fc receptor mediates transport of IgG into luminal secretions for delivery of antigens to mucosal dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

CD27 expression in the human splenic marginal zone: the infant marginal zone is populated by naive B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

The dual function of the splenic marginal zone: essential for initiation of anti-TI-2 responses but also vital in the general first-line defense against blood-borne antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Unique CD40-mediated biological program in B cell activation requires both type 1 and type 2 NF-kappaB activation pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

B cell memory to thymus-independent antigens type 1 and type 2: the role of lipopolysaccharide in B memory induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Somatic hypermutation and diverse immunoglobulin gene usage in the human antibody response to the capsular polysaccharide of Streptococcus pneumoniae Type 6B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Induction of interleukin-8 in T84 cells by Vibrio cholerae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Quorum-sensing regulators control virulence gene expression in Vibrio cholerae

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Human marginal-zone B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

Induction of Protective Immunity by SyntheticVibrio choleraeHexasaccharide Derived fromV. choleraeO1 Ogawa Lipopolysaccharide Bound to a Protein Carrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03866.X

The 1968-1969 cholera-vaccine field trial in rural East Pakistan. Effectiveness of monovalent Ogawa and Inaba vaccines and a purified Inaba antigen, with comparative results of serological and animal protection tests

21 January 2018

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/citations/10.1093/INFDIS/121.SUPPLEMENT.S1

Identifiers

DOI

10.1111/J.1348-0421.2006.TB03866.X

1 reference

15 August 2017

1 reference